2017

1. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

   Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

2. The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study

   Gastroenterologia y Hepatologia, Vol. 40, Núm. 8, pp. 515-524